Ma Heng Jun - Net Worth and Insider Trading
Ma Heng Jun Net Worth
The estimated net worth of Ma Heng Jun is at least $90 Million dollars as of 2025-04-27. Ma Heng Jun is the senior management of Chengdu Olymvax Biopharmaceuticals Inc and owns about 5,783,146 shares of Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) stock worth over $90 Million. Details can be seen in Ma Heng Jun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ma Heng Jun has not made any transactions after 2024-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ma Heng Jun
Ma Heng Jun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ma Heng Jun owns 1 companies in total, including Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) .
Click here to see the complete history of Ma Heng Jun’s form 4 insider trades.
Insider Ownership Summary of Ma Heng Jun
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:688319 | Chengdu Olymvax Biopharmaceuticals Inc | 2024-07-15 | senior management |
Ma Heng Jun Latest Holdings Summary
Ma Heng Jun currently owns a total of 1 stock. Ma Heng Jun owns 5,783,146 shares of Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) as of July 15, 2024, with a value of $90 Million.
Latest Holdings of Ma Heng Jun
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:688319 | Chengdu Olymvax Biopharmaceuticals Inc | 2024-07-15 | 5,783,146 | 15.58 | 90,101,415 |
Holding Weightings of Ma Heng Jun
Ma Heng Jun Form 4 Trading Tracker
According to the SEC Form 4 filings, Ma Heng Jun has made a total of 4 transactions in Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Chengdu Olymvax Biopharmaceuticals Inc is the sale of 31,800 shares on July 15, 2024, which brought Ma Heng Jun around $337,398.
Insider Trading History of Ma Heng Jun
- 1
Ma Heng Jun Trading Performance
GuruFocus tracks the stock performance after each of Ma Heng Jun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ma Heng Jun is 7.45%. GuruFocus also compares Ma Heng Jun's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ma Heng Jun within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ma Heng Jun's insider trading performs compared to the benchmark.
Ma Heng Jun Ownership Network
Ownership Network List of Ma Heng Jun
Ownership Network Relation of Ma Heng Jun

Ma Heng Jun Owned Company Details
What does Chengdu Olymvax Biopharmaceuticals Inc do?
Who are the key executives at Chengdu Olymvax Biopharmaceuticals Inc?
Ma Heng Jun is the senior management of Chengdu Olymvax Biopharmaceuticals Inc. Other key executives at Chengdu Olymvax Biopharmaceuticals Inc include Core technical personnel Chen Dao Yuan , Core technical personnel Li Hong Guang , and Directors & senior managers Fan Shao Wen .
Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) Insider Trades Summary
Over the past 18 months, Ma Heng Jun made 1 insider transaction in Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) with a net sale of 0. Other recent insider transactions involving Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) include a net sale of 232,054 shares made by Chen Dao Yuan , a net sale of 64,000 shares made by Li Hong Guang , and a net sale of 30,000 shares made by Chen Ke Ping .
In summary, during the past 3 months, insiders sold 120,000 shares of Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) in total and bought 0 shares, with a net sale of 120,000 shares. During the past 18 months, 341,054 shares of Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) were sold and 0 shares were bought by its insiders, resulting in a net sale of 341,054 shares.
Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chengdu Olymvax Biopharmaceuticals Inc Insider Transactions
Ma Heng Jun Mailing Address
Above is the net worth, insider trading, and ownership report for Ma Heng Jun. Currently GuruFocus does not have mailing address information for Ma Heng Jun.